Accuray (ARAY) Depreciation & Amortization (CF) (2010 - 2026)
Accuray's (ARAY) quarterly Depreciation & Amortization (CF) came in at $2.1 million in Q1 2026, down 54.35% year-on-year from $4.6 million in Q1 2025, and down 3.93% quarter-over-quarter from $2.2 million in Q4 2025.
Accuray (ARAY) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Accuray's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 54.35% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $5.9 million, a 21.41% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, up 4.15% from the prior year.
- Depreciation & Amortization (CF) declined to $2.1 million in Q1 2026 per ARAY's latest filing, from $2.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $4.6 million in Q1 2025 and bottomed at $1.2 million in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $1.7 million (2025), against an average of $2.4 million.
- Across the five-year window, Depreciation & Amortization (CF) soared 42.96% in 2025 and slumped 54.35% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $1.2 million in 2022, then surged by 34.32% to $1.5 million in 2023, then slipped by 2.13% to $1.5 million in 2024, then jumped by 42.96% to $2.2 million in 2025, then slipped by 3.93% to $2.1 million in 2026.
- Per Business Quant, the three latest ARAY Depreciation & Amortization (CF) figures stand at $2.1 million (Q1 2026), $2.2 million (Q4 2025), and $1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Accuray | 29,348.17 | -38.50 Mn | 25.29 Mn | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 4.40 Mn |
| Mar 31, 2024 | 4.40 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 3.43 Mn |
| Mar 31, 2023 | 3.43 Mn |